Navigation Links
Engineers create 3-D model to help biologists combat blue tongue virus

A large 3D model of the Blue Tongue virus has been created by WMG engineering researchers at the University of Warwick that will help biologists devise new ways to combat the virus and protect millions of livestock from infection.

The WMG University of Warwick researchers based their model on data provided by the Institute of Animal Health at Pirbright, and from Oxford University. The Warwick team used rapid prototyping technology, normally used to create highly accurate 3D copies of components for a range of manufacturing processes, to create an accurate 3D model virus that is 5,200,000 times the size of the real thing.

Dr Greg Gibbons, who leads the University of Warwick's WMG's rapid prototyping team, is working with Professor Peter Mertens, head of the Arbovirus Research Group at the Institute of Animal Health at Pirbright, and Robert Esnouf of Oxford.

Dr Gibbons said: "Research collaboration between engineers and biologists is rare although we have worked with Oxford and the IAH before. The physical model we've created is based on the same technology we use to quickly and cheaply create models of, for example, car parts; used by manufacturers to develop designs and test products before going into full-scale production."

The insect-borne virus is most commonly seen in the late summer and autumn and can devastate herds of sheep and cattle.

Professor Mertens said: "Blue Tongue represents the worst threat to agriculture this country has seen for 20 years. In its first year in Belgium it wiped out 100 sheep, but in its second year it wiped out 30,000. In Britain we have 34 million sheep we could be looking at losing up to 20 per cent of that population."

"I don't know of any other way to create a scientifically accurate model of a virus. By using the computer models we've generated we can feed that information into the machines at WMG and create an absolutely perfect model of the real virus."

"The model will help us to understand how the molecules and proteins interact with one another and this could help us to develop new anti-viral drugs. Having a physical model that you can pick up and peer at will make a huge difference."


Contact: Peter Dunn
University of Warwick

Related biology news :

1. Bioengineers at University of Pennsylvania devise nanoscale system to measure cellular forces
2. Princeton engineers develop low-cost recipe for patterning microchips
3. UCR engineers to develop new tool to measure how environmental exposures affect health
4. Boston University biomedical engineers find chink in bacterias armor
5. CU researcher engineers sorghum that grows in poisonous soils
6. Institution of Chemical Engineers chooses Elsevier as publishing partner
7. Engineers study brain folding in higher mammals
8. Nanoengineers mine tiny diamonds for drug delivery
9. President honors mentors of scientists and engineers
10. Penn engineers create carbon nanopipettes that are smaller than cells and measure electric current
11. Elephant engineers
Post Your Comments:
Related Image:
Engineers create 3-D model to help biologists combat  blue tongue virus
(Date:11/19/2015)... , Nov. 19, 2015  Although some 350 ... is dominated by a few companies, according to Kalorama ... own 51% of the market share of the 6.1 ... The World Market for Molecular Diagnostic s . ... "The market is still controlled by one company and ...
(Date:11/17/2015)... 2015  Vigilant Solutions announces today that Mr. ... Directors. --> --> ... the partnership at TPG Capital, one of the largest ... Billion in revenue.  He founded and led TPG,s Operating ... companies, from 1997 to 2013.  In his first role, ...
(Date:11/12/2015)...   Growing need for low-cost, easy to ... paving the way for use of biochemical sensors ... in clinical, agricultural, environmental, food and defense applications. ... medical applications, however, their adoption is increasing in ... emphasis on improving product quality and growing need ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) ... quarter ended September 30, 2015. Amounts, unless specified ... under International Financial Reporting Standards ("IFRS"). ... Andrew Rae , President & CEO of iCo ... value enriching for this clinical program, but also ...
(Date:11/24/2015)... , Nov. 24, 2015  Clintrax Global, Inc., a worldwide provider ... , today announced that the company has set a new ... 391% quarter on quarter growth posted for Q3 of 2014 to ... and Mexico , with the establishment of an ... 2015. --> United Kingdom and ...
(Date:11/24/2015)... SHPG ) announced today that Jeff Poulton , ... Annual Healthcare Conference in New York City ... (1:30 p.m. GMT). --> SHPG ) announced today that ... Piper Jaffray 27 th Annual Healthcare Conference in ... at 8:30 a.m. EST (1:30 p.m. GMT). --> Shire ...
(Date:11/24/2015)... SAN FRANCISCO , Nov. 24, 2015 /PRNewswire/ ... today announced that Emily Leproust, Ph.D., Twist Bioscience ... Piper Jaffray Healthcare Conference on December 1, 2015 ... Palace Hotel in New York City. ... . Twist Bioscience is on ...
Breaking Biology Technology: